Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience
Open Access
- 31 January 2007
- journal article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 13 (1), 116-123
- https://doi.org/10.1016/j.bbmt.2006.09.005
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-upBone Marrow Transplantation, 2005
- In-vivo generation of leukaemia-derived dendritic cellsBest Practice & Research Clinical Haematology, 2004
- Efficacy and safety of imatinib mesylate (Glivec™) in combination with interferon-α (IFN-α) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)Leukemia, 2003
- Donor Lymphocyte Infusions for Patients who Relapse After Allogeneic Stem Cell Transplantation for Chronic Myeloid LeukaemiaLeukemia & Lymphoma, 2003
- Efficacy of imatinib mesylate (STI571) in conjunction with alpha-interferon: long-term quantitative molecular remission in relapsed P-190BCR-ABL-positive acute lymphoblastic leukemiaLeukemia, 2002
- Acute Lymphoblastic LeukemiaHematology, 2002
- Chemotherapy and granulocyte colony stimulating factor‐mobilized blood cell infusion followed by interferon‐α for relapsed malignancy after allogeneic bone marrow transplantationInternal Medicine Journal, 2001
- Sensitivity of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation to immunotherapy with interferon-α2bBone Marrow Transplantation, 1997
- Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapyBone Marrow Transplantation, 1997
- Unexpected remission of acute myeloid leukaemia after GM‐CSFBritish Journal of Haematology, 1994